CenterHumanNatureAINeuroscience $CHAIN
69
PumpScore 69/100 Grade B
CHAIN, the ticker for CenterHumanNatureAINeuroscience, scores 69 out of 100 on PumpScore as of Aug 15, 2026 08:00. That grade reflects thin liquidity, active 24-hour volume and balanced order flow on the Solana blockchain.
Score breakdown
The biggest contributor to its score is trade participation (100/100), while survival time (2/100) is the weakest link holding it back.
Liquidity depth36
Liquidity vs market cap100
24h trading volume87
Healthy turnover55
Buy / sell balance86
Trade participation100
Survival time2
Market-cap tier27
Price stability91
Volume vs liquidity82
Price
$0.00000313
Market Cap
$3.1K
24h Volume
$47.6K
Liquidity
$2.8K
24h Change
-89.99%
24h Buys / Sells
594 / 624
Tip Low on trading activity? Many Solana creators use a volume bot for Pump.fun to build steady volume and chase King of the Hill.
Contract
BP42NQ7tkcxq82AXgC1i5wT1QtUNCUUJvQyULeQbpump
Frequently asked questions
When did CHAIN launch?
CenterHumanNatureAINeuroscience launched on Pump.fun about 57 min ago. Survival time is part of the score - the longer a token trades without collapsing, the more its structure is trusted.
Where can I buy CHAIN?
You can find CenterHumanNatureAINeuroscience on Pump.fun and Solana DEXs. Verify the exact contract address on a block explorer first, since copycat tickers are common.
What is the market cap of CenterHumanNatureAINeuroscience?
As of Aug 15, 2026 08:00, CHAIN trades at $0.00000313 with a market cap near $3.1K, $47.6K of 24h volume and $2.8K of liquidity. It moved -89.99% over the last day.
How is CHAIN rated on PumpScore?
CenterHumanNatureAINeuroscience (CHAIN) has a PumpScore of 69/100 - Grade B, healthy - as of Aug 15, 2026 08:00. The rating is built from 10 live on-chain signals such as liquidity, volume, buy/sell balance and survival time.
Can I trust CenterHumanNatureAINeuroscience?
No score can prove CHAIN is safe. CenterHumanNatureAINeuroscience carries thin liquidity and a 69/100 structure read, but brand-new tokens can fail regardless. Treat this as data, not advice.
